![]() ![]() Inflammation plays a significant role in the formation of atherosclerotic plaques and Atherosclerotic Cardiovascular Disease (ASCVD), the condition where the arteries become narrowed and hardened due to the buildup of plaque, which can lead to heart attacks and strokes, and other cardiovascular events. Lodoco is the first anti-inflammatory atheroprotective cardiovascular treatment to be FDA-approved. Lodoco can be used by adult patients who have a known buildup of plaque inside the arteries (atherosclerotic disease) or have other risk factors for cardiovascular disease. ![]() Lodoco (colchicine) is used for cardiovascular disease to reduce the risk of heart attack, stroke, cardiac stenting, coronary artery bypass graft, and cardiovascular death. Medically reviewed by Melisa Puckey, BPharm.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |